Engineering an ACE2-Derived Fragment as a Decoy for Novel SARS-CoV-2 Virus
- 22 May 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 6 (6) , 857-867
Abstract
Entry inhibitors are an important resource in the response against emerging pathogens like the novel SARS-CoV-2, which enters human cells via interaction between the surface spike glycoprotein and the cellular membrane receptor angiotensin-converting enzyme 2 (ACE2). Using a combination of comparative structural analyses of the binding surface of the spike to ACE2, docking experiments, and molecular dynamics simulations, we identified a stable fragment of ACE2 that binds to the spike, is soluble, and is not predicted to bind to its physiological ligand angiotensin II. From this fragment we computationally designed and experimentally validated a smaller, stable peptide that disrupts ACE2-spike interaction at nanomolar concentrations, suggesting its potential use as a decoy that could interfere with viral binding by competition.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (AI129745)
- University of Nebraska Omaha
- National Institute on Drug Abuse (DA052845)
- COVID-19 Rapid Response
- University of Nebraska System
This publication has 40 references indexed in Scilit:
- GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkitBioinformatics, 2013
- Molecular recognition and regulation of human angiotensin-I converting enzyme (ACE) activity by natural inhibitory peptidesScientific Reports, 2012
- Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike ProteinViruses, 2012
- Benchmarking and Analysis of Protein Docking Performance in Rosetta v3.2PLOS ONE, 2011
- Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptorProceedings of the National Academy of Sciences, 2009
- Angiotensin II Up-Regulates Angiotensin I-Converting Enzyme (ACE), but Down-Regulates ACE2 via the AT1-ERK/p38 MAP Kinase PathwayThe American Journal of Pathology, 2008
- ACE2 Receptor Expression and Severe Acute Respiratory Syndrome Coronavirus Infection Depend on Differentiation of Human Airway EpitheliaJournal of Virology, 2005
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- ACE2 X-Ray Structures Reveal a Large Hinge-bending Motion Important for Inhibitor Binding and CatalysisJournal of Biological Chemistry, 2004
- GROMACS: A message-passing parallel molecular dynamics implementationComputer Physics Communications, 1995